Please complete the CAPTCHA to continue
@comcast.net
✓
1 phone found area 509
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Michael G. Oefelein, Md, Facs is listed as Founder and Chief Medical Officer at LIPAC ONCOLOGY/ Board member/ Entrepreneur/ Physician at LIPAC ONCOLOGY, based in Orange County, California, United States. AeroLeads shows a work email signal at comcast.net, phone signal with area code 509, and a matched LinkedIn profile for Michael G. Oefelein, Md, Facs.
Michael G. Oefelein, Md, Facs previously worked as Chief Medical Officer, founder at Lipac Oncology and Attending Physician and Surgeon at Lipac Oncology. Michael G. Oefelein, Md, Facs holds Post-Graduate Surgical And Urology, Surgery And Urology from Northwestern University.
This section adds company-level context without repeating Michael G. Oefelein, Md, Facs's masked contact details.
AeroLeads found 1 current-domain work email signal for Michael G. Oefelein, Md, Facs. Compare company email patterns before reaching out.
Dr. Oefelein is a board certified physician and a Fellow of the American College of Surgeons with extensive experience (> 15 year) in the pharmaceutical and the device industry—including dermatology, urology, oncology, ophthalmology and plastic and bariatric surgery. He has authored nearly 100 peer reviewed publications, and he has delivered numerous scientific presentations at regional, national and international venues. He has designed and executed clinical trials for a number of purposes, including: NDA/registration trials, differentiation, pharmaco- economic, value, label change, safety, drug-drug interaction, dose-ranging, IND/NDA and IDE/PMA. Dr. Oefelein has helped develop several Genitourinary oncology drugs: Degarelix, Zometa and Apaziquone, and non-oncology drugs: Levaquin, Botox, Serenity-120, and Devices: Seriscaffold, Breast implants, HA-fillers and surgical navigations systems. He is an active member of numerous medical societies, including the Society of Urological Oncology, SUFU, AUA, American College of Surgeons and Laparoscopic surgeons. Dr. Oefelein has led several device (Silicone breast implants, Lap-Band) and pharmaceutical (Bimatoprost, Latisse, Sanctura XR) safety evaluations. Dr Oefelein has developed scientific content for, and he has led, numerous advisory board meetings, and he has translated the meeting output into enduring materials. He has developed numerous publication and differentiation plans for a wide range of pharmaceutical and device assets. In summary, Dr. Oefelein has diverse academic, pharmaceutical and device experiences, and a track record of success.Board certified SurgeonDrug and device developmentClinical trials and publicationsRegulatory and safety experienceAgency communications and panel experienceBudget and management of large teams and projectsSpecialties: Scientific development, differentiation and communication in Surgery, Urology, Oncology, Dermatology, Plastic surgery.
Listed skills include Clinical Trials, Urology, Oncology, Aesthetics, and 27 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
LIPAC ONCOLOGY is focused on the pro-liposomal formulation platform to treat Non-Muscle Invasive Bladder Cancer (NMIBC), Upper Tract Urothelial Cancer (UTUC), Ovarian cancer, peritoneal cancer, and cancers of the thoracic cavity.
Urology, Urological Oncology
Suwanee, Georgia, Us
Developed surgical navigation and image guidance device for real-time intra-operative surgical guidance
Dublin, Coolock, Ie
Scientific differentiation and communication of the Allergan Medical portfolio including the facial aesthetic portfolio (Botox Cosmetic, Juverderm family of Fillers, Latisse), the plastic surgery portfolio (Natrelle Breast implants, Seri-Scaffold and Vectra-Precision Light), and the health portfolio (Lap-Band, Intra-gastric balloon) through phase 3b and 4 clinical trials, publications, and scientific engagement.
Dublin, Coolock, Ie
Budget, clinical trial, publication, pharmacoeconomic and Regional Scientific Specialists Training responsibilities for approved pharmaceuticals, and member of core clinical developmental team.
Dublin, Coolock, Ie
Scieintific differentiaition of the developing Allergan Urology portfolio including Botox Neurogenic Detrussor Overactivity, Botox idiopathic Overactive Bladder, Botox for signs and symptoms of BPH, Serenity for Nocturia, Apaziquone for non-muscle invasive bladder cancer, and Sanctura XR for overactive bladder through late phase clinical trials, publications, training and scientific engagements.The job also included scientific asset due diligence for buisness development culminating in 3 closed deals and assessing 22 additional urological assets.
Academic physician surgeon; Taught first through fourth year medical students, post-graduate interns and residents, and was faculty member for mini-medical school.Member of Case Western Reserve University SenateJournal editor reviewer for: J. Urology, Lancet, Cancer, Urology, J Society of Urological Oncology.
Quick answers generated from the profile data available on this page.
Michael G. Oefelein, Md, Facs works for LIPAC ONCOLOGY.
Michael G. Oefelein, Md, Facs is listed as Founder and Chief Medical Officer at LIPAC ONCOLOGY/ Board member/ Entrepreneur/ Physician at LIPAC ONCOLOGY.
AeroLeads has found 1 work email signal at @comcast.net for Michael G. Oefelein, Md, Facs at LIPAC ONCOLOGY.
AeroLeads has found 1 phone signal(s) with area code 509 for Michael G. Oefelein, Md, Facs at LIPAC ONCOLOGY.
Michael G. Oefelein, Md, Facs is based in Orange County, California, United States while working with LIPAC ONCOLOGY.
Michael G. Oefelein, Md, Facs has worked for Lipac Oncology, Riverwalk Surgical Associates, Digirad, Allergan, and Ireland Cancer Center-Case Western Reserve University.
You can use AeroLeads to view verified contact signals for Michael G. Oefelein, Md, Facs at LIPAC ONCOLOGY, including work email, phone, and LinkedIn data when available.
Michael G. Oefelein, Md, Facs holds Post-Graduate Surgical And Urology, Surgery And Urology from Northwestern University.
Michael G. Oefelein, Md, Facs is listed with skills including Clinical Trials, Urology, Oncology, Aesthetics, Cancer, Health, Dermatology, and Clinical Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts